USA Candesartan Cilexetil Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Candesartan cilexetil (candesartan) is a drug used for treating high blood pressure (hypertension). It is in a class of drugs called angiotensin receptor blockers (ARBs) which includes losartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro). Angiotensin, formed in the blood by the action of angiotensin converting enzyme (ACE), is a powerful chemical that attaches to angiotensin receptors found in many tissues but primarily on smooth muscle cells surrounding blood vessels. Angiotensin's attachment to the receptors causes the muscle cells to contract and the blood vessels to narrow (vasoconstrict) which leads to an increase in blood pressure. Candesartan blocks the angiotensin receptor and therby prevents the action of angiotensin. As a result blood vessels expand and blood pressure is reduced. Candesartan was approved by the FDA in 1998.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Candesartan Cilexetil Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Candesartan Cilexetil Drug market. Detailed analysis of key players, along with key growth strategies adopted by Candesartan Cilexetil Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Zydus Pharmaceuticals

    • Teva

    • Mylan

    • ANI Pharmaceuticals

    • Chongqing Shenghuaxi Pharma

    • AstraZeneca

    • LUPIN

    • Alembic Pharmaceuticals

    • Sun Pharmaceutical

    • MACLEODS

    By Type:

    • 4 mg Tablets

    • 8 mg Tablets

    • 16 mg Tablets

    • 32 mg Tablets

    By End-User:

    • Essential hypertension in adults

    • Hypertension in children and adolescents aged 6 to < 18 years

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Candesartan Cilexetil Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Candesartan Cilexetil Drug Market Size and Growth Rate of 4 mg Tablets from 2016 to 2027

      • 1.3.2 USA Candesartan Cilexetil Drug Market Size and Growth Rate of 8 mg Tablets from 2016 to 2027

      • 1.3.3 USA Candesartan Cilexetil Drug Market Size and Growth Rate of 16 mg Tablets from 2016 to 2027

      • 1.3.4 USA Candesartan Cilexetil Drug Market Size and Growth Rate of 32 mg Tablets from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Candesartan Cilexetil Drug Market Size and Growth Rate of Essential hypertension in adults from 2016 to 2027

      • 1.4.2 USA Candesartan Cilexetil Drug Market Size and Growth Rate of Hypertension in children and adolescents aged 6 to < 18 years from 2016 to 2027

      • 1.4.3 USA Candesartan Cilexetil Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Candesartan Cilexetil Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Candesartan Cilexetil Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of 4 mg Tablets

      • 3.4.2 Market Size and Growth Rate of 8 mg Tablets

      • 3.4.3 Market Size and Growth Rate of 16 mg Tablets

      • 3.4.4 Market Size and Growth Rate of 32 mg Tablets

    4 Segmentation of Candesartan Cilexetil Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Candesartan Cilexetil Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Candesartan Cilexetil Drug in Essential hypertension in adults

      • 4.4.2 Market Size and Growth Rate of Candesartan Cilexetil Drug in Hypertension in children and adolescents aged 6 to < 18 years

      • 4.4.3 Market Size and Growth Rate of Candesartan Cilexetil Drug in Others

    5 Market Analysis by Regions

    • 5.1 USA Candesartan Cilexetil Drug Production Analysis by Regions

    • 5.2 USA Candesartan Cilexetil Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Candesartan Cilexetil Drug Landscape Analysis

    • 6.1 West USA Candesartan Cilexetil Drug Landscape Analysis by Major Types

    • 6.2 West USA Candesartan Cilexetil Drug Landscape Analysis by Major End-Users

    7 South USA Candesartan Cilexetil Drug Landscape Analysis

    • 7.1 South USA Candesartan Cilexetil Drug Landscape Analysis by Major Types

    • 7.2 South USA Candesartan Cilexetil Drug Landscape Analysis by Major End-Users

    8 Middle West USA Candesartan Cilexetil Drug Landscape Analysis

    • 8.1 Middle West USA Candesartan Cilexetil Drug Landscape Analysis by Major Types

    • 8.2 Middle West USA Candesartan Cilexetil Drug Landscape Analysis by Major End-Users

    9 Northeast USA Candesartan Cilexetil Drug Landscape Analysis

    • 9.1 Northeast USA Candesartan Cilexetil Drug Landscape Analysis by Major Types

    • 9.2 Northeast USA Candesartan Cilexetil Drug Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Zydus Pharmaceuticals

        • 10.1.1 Zydus Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Teva

        • 10.2.1 Teva Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Mylan

        • 10.3.1 Mylan Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 ANI Pharmaceuticals

        • 10.4.1 ANI Pharmaceuticals Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Chongqing Shenghuaxi Pharma

        • 10.5.1 Chongqing Shenghuaxi Pharma Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 AstraZeneca

        • 10.6.1 AstraZeneca Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 LUPIN

        • 10.7.1 LUPIN Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Alembic Pharmaceuticals

        • 10.8.1 Alembic Pharmaceuticals Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Sun Pharmaceutical

        • 10.9.1 Sun Pharmaceutical Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 MACLEODS

        • 10.10.1 MACLEODS Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of 4 mg Tablets from 2016 to 2027

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of 8 mg Tablets from 2016 to 2027

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of 16 mg Tablets from 2016 to 2027

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of 32 mg Tablets from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of Essential hypertension in adults from 2016 to 2027

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of Hypertension in children and adolescents aged 6 to < 18 years from 2016 to 2027

    • Figure USA Candesartan Cilexetil Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Candesartan Cilexetil Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Candesartan Cilexetil Drug

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Candesartan Cilexetil Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Candesartan Cilexetil Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 4 mg Tablets

    • Figure Market Size and Growth Rate of 8 mg Tablets

    • Figure Market Size and Growth Rate of 16 mg Tablets

    • Figure Market Size and Growth Rate of 32 mg Tablets

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Candesartan Cilexetil Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Candesartan Cilexetil Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Essential hypertension in adults

    • Figure Market Size and Growth Rate of Hypertension in children and adolescents aged 6 to < 18 years

    • Figure Market Size and Growth Rate of Others

    • Table USA Candesartan Cilexetil Drug Production by Regions

    • Table USA Candesartan Cilexetil Drug Production Share by Regions

    • Figure USA Candesartan Cilexetil Drug Production Share by Regions in 2016

    • Figure USA Candesartan Cilexetil Drug Production Share by Regions in 2021

    • Figure USA Candesartan Cilexetil Drug Production Share by Regions in 2027

    • Table USA Candesartan Cilexetil Drug Consumption by Regions

    • Table USA Candesartan Cilexetil Drug Consumption Share by Regions

    • Figure USA Candesartan Cilexetil Drug Consumption Share by Regions in 2016

    • Figure USA Candesartan Cilexetil Drug Consumption Share by Regions in 2021

    • Figure USA Candesartan Cilexetil Drug Consumption Share by Regions in 2027

    • Table West USA Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027

    • Table West USA Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027

    • Figure West USA Candesartan Cilexetil Drug Consumption Share by Types in 2016

    • Figure West USA Candesartan Cilexetil Drug Consumption Share by Types in 2021

    • Figure West USA Candesartan Cilexetil Drug Consumption Share by Types in 2027

    • Table West USA Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027

    • Table West USA Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2016

    • Figure West USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2021

    • Figure West USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2027

    • Table South USA Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027

    • Table South USA Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027

    • Figure South USA Candesartan Cilexetil Drug Consumption Share by Types in 2016

    • Figure South USA Candesartan Cilexetil Drug Consumption Share by Types in 2021

    • Figure South USA Candesartan Cilexetil Drug Consumption Share by Types in 2027

    • Table South USA Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027

    • Table South USA Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2016

    • Figure South USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2021

    • Figure South USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2027

    • Table Middle West USA Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027

    • Table Middle West USA Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Share by Types in 2016

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Share by Types in 2021

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Share by Types in 2027

    • Table Middle West USA Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2016

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2021

    • Figure Middle West USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2027

    • Table Northeast USA Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027

    • Table Northeast USA Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Share by Types in 2016

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Share by Types in 2021

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Share by Types in 2027

    • Table Northeast USA Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2016

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2021

    • Figure Northeast USA Candesartan Cilexetil Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Zydus Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Zydus Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Zydus Pharmaceuticals

    • Table Product and Service Introduction of Zydus Pharmaceuticals

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of ANI Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ANI Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of ANI Pharmaceuticals

    • Figure Revenue and Market Share Analysis of ANI Pharmaceuticals

    • Table Product and Service Introduction of ANI Pharmaceuticals

    • Table Company Profile and Development Status of Chongqing Shenghuaxi Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chongqing Shenghuaxi Pharma

    • Figure Sales and Growth Rate Analysis of Chongqing Shenghuaxi Pharma

    • Figure Revenue and Market Share Analysis of Chongqing Shenghuaxi Pharma

    • Table Product and Service Introduction of Chongqing Shenghuaxi Pharma

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of LUPIN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LUPIN

    • Figure Sales and Growth Rate Analysis of LUPIN

    • Figure Revenue and Market Share Analysis of LUPIN

    • Table Product and Service Introduction of LUPIN

    • Table Company Profile and Development Status of Alembic Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alembic Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alembic Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alembic Pharmaceuticals

    • Table Product and Service Introduction of Alembic Pharmaceuticals

    • Table Company Profile and Development Status of Sun Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

    • Table Product and Service Introduction of Sun Pharmaceutical

    • Table Company Profile and Development Status of MACLEODS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MACLEODS

    • Figure Sales and Growth Rate Analysis of MACLEODS

    • Figure Revenue and Market Share Analysis of MACLEODS

    • Table Product and Service Introduction of MACLEODS


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.